Integrated Biopharma Inc (INBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INBP | IKT | CANF | ||
| Company | Integrated Biopharma Inc | Inhibikase Therapeutics Inc | Can-Fite Biopharma Ltd ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE Arca | ||
| Open | 0.2300 | 1.1300 | 2.08 | ||
| High | 0.2499 | 1.1700 | 2.08 | ||
| Low | 0.2300 | 1.1300 | 1.95 | ||
| Last | 0.2499 | 1.1500 | 2.05 | ||
| Change | +0.0219 | +0.0200 | +0.02 | ||
| % Change | +9.61% | +1.77% | +0.99% | ||
| Volume | 4,800 | 17,100 | 89,100 | ||
| 20-Day Average Volume | 16,355 | 18,850 | 134,930 | ||
| Previous Close | 0.2280 | 1.1300 | 2.03 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2082 | 1.2528 | 2.21 | ||
| 20-Day Raw Stochastic | 100.00% | 7.69% | 29.01% | ||
| 20-Day Relative Strength | 57.27% | 39.51% | 39.80% | ||
| Weighted Alpha | -4.09 | -51.98 | -52.73 | ||
| Today's Opinion | 48% Sell | 100% Sell | 56% Sell | ||
| Previous Opinion | 72% Sell | 100% Sell | 40% Sell | ||
| Last Month's Opinion | 96% Sell | 64% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.70% since 09/11/24 | -0.89% since 09/19/24 | +1.49% since 09/19/24 | ||
| Low | 0.1995 on 09/18/24 | 1.1200 on 09/25/24 | 1.87 on 09/20/24 | ||
| High | 0.2499 on 09/23/24 | 1.2400 on 09/23/24 | 2.20 on 09/24/24 | ||
| 1-Month | |||||
| %Chg | +24.95% since 08/16/24 | -20.69% since 08/26/24 | -14.58% since 08/26/24 | ||
| Low | 0.1735 on 09/03/24 | 1.1200 on 09/25/24 | 1.87 on 09/20/24 | ||
| High | 0.2499 on 09/23/24 | 1.5100 on 09/10/24 | 2.50 on 09/13/24 | ||
| 3-Month | |||||
| %Chg | +11.96% since 06/12/24 | -18.44% since 06/26/24 | -22.64% since 06/26/24 | ||
| Low | 0.1638 on 08/15/24 | 1.1200 on 09/25/24 | 1.87 on 09/20/24 | ||
| High | 0.2499 on 09/23/24 | 1.7300 on 07/26/24 | 4.69 on 07/22/24 | ||
| 6-Month | |||||
| %Chg | +8.84% since 03/22/24 | -49.78% since 03/26/24 | -5.96% since 03/26/24 | ||
| Low | 0.1638 on 08/15/24 | 1.1200 on 09/25/24 | 1.87 on 09/20/24 | ||
| High | 0.2500 on 05/29/24 | 2.4448 on 03/28/24 | 4.69 on 07/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,522 | 8,154 | 7,187 | ||
| Shares Outstanding, K | 30,100 | 7,216 | 3,540 | ||
| Annual Sales | 50,320,000 | 260,000 | 740,000 | ||
| Annual Net Income | 110,000 | -19,030,000 | -7,630,000 | ||
| Last Quarter Sales | 12,750,000 | 0 | 160,000 | ||
| Last Quarter Net Income | 270,000 | -4,960,000 | -1,650,000 | ||
| 60-Month Beta | 0.67 | 1.33 | 1.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 09/20/24 | -0.66 on 08/14/24 | -0.31 on 03/28/24 | ||
| Latest Earnings Date | 11/14/24 | 11/12/24 | 09/26/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 22.80 | 0.00 | 0.00 | ||